Me Medicine vs We Medicine
Friday 28 March 2014
Oxford Martin School: Seminar RoomVenue
Award-winning expert on health ethics Professor Donna Dickenson questions the rise of ‘me medicine’ or personalised healthcare. Me medicine, she argues, is radically transforming ‘we medicine’ or the one-size-fits-all model of healthcare such as vaccination. Technologies such as direct-to-consumer genetic testing claim to cater to a person’s individual biological character. Some of these new personalised health technologies have shown powerful potential, says Dickenson, but others have produced little or negative effects. And she questions why me medicine is edging out we medicine and whether our commitment to collective health could suffer as a result.
Dickenson is professor emerita of medical ethics at the University of London and research associate at the Centre for Health, Law, and Emerging Technologies at the University of Oxford. She is author of Body Shopping: Converting Body Parts to Profit, and is the first and only woman to win the International Spinoza Lens award for her contribution to public debate on ethics.